PTGS2 and neoplasm: The tumor incidence and multiplicity were suppressed after GLT administration (0–500 mg/kg for 17 weeks), and the mechanism was revealed to be correlated with the inhibition of cyclin D1 and COX-2 expression in colon tissue (Sliva et al., 2012).